An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.

[1]  D. Munn,et al.  Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. , 2022, Cancer cell.

[2]  Wei-Lin Jin,et al.  Reclassification of Hepatocellular Cancer With Neural-Related Genes , 2022, Frontiers in Oncology.

[3]  Jinfeng Zhu,et al.  Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma , 2022, Frontiers in Oncology.

[4]  M. Hiramoto,et al.  Lysosome-targeted drug combination induces multiple organelle dysfunctions and non-canonical death in pancreatic cancer cells , 2021, Oncology reports.

[5]  S. Koyama,et al.  Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies , 2021, Journal for ImmunoTherapy of Cancer.

[6]  N. Mishra,et al.  Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers , 2021, Cancers.

[7]  S. Pauklin,et al.  TGFB1/INHBA homodimer/Nodal-SMAD2/3 Signalling Network: A Pivotal Molecular Target in PDAC Treatment. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Afshin Samali,et al.  An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer , 2021, Cancers.

[9]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[10]  Xi Chen,et al.  Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.

[11]  Xianjun Yu,et al.  Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma , 2020, Journal of Hematology & Oncology.

[12]  T. Rana,et al.  m6A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy , 2020, The EMBO journal.

[13]  P. Ohashi,et al.  The Roles of CD8+ T Cell Subsets in Antitumor Immunity. , 2020, Trends in cell biology.

[14]  E. O’Reilly,et al.  New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma , 2020, Drugs.

[15]  Myung Ah Lee,et al.  Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial. , 2019, JAMA oncology.

[16]  C. Sautès-Fridman,et al.  Tertiary lymphoid structures in the era of cancer immunotherapy , 2019, Nature Reviews Cancer.

[17]  K. Olive,et al.  Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase‐1 inhibition , 2019, Translational research : the journal of laboratory and clinical medicine.

[18]  Bas Groot Koerkamp,et al.  International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer , 2018, JAMA surgery.

[19]  Miao Yin,et al.  CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer. , 2018, Cell reports.

[20]  J. García-Foncillas,et al.  New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review , 2018, International journal of molecular sciences.

[21]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[22]  Joshua M. Stuart,et al.  Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. , 2018, Cell.

[23]  Judith A. Smith.  Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity , 2018, Front. Immunol..

[24]  Wei‐Chao Chang,et al.  Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. , 2018, Cancer letters.

[25]  C. Iacobuzio-Donahue,et al.  Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases , 2017, Science.

[26]  Z. Nwosu,et al.  Caveolin-1 in the regulation of cell metabolism: a cancer perspective , 2016, Molecular Cancer.

[27]  D. Rades,et al.  Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action , 2015, Molecular Cancer.

[28]  Hyun-Jong Cho,et al.  Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells , 2014, Oncotarget.

[29]  R. Kaufman,et al.  The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.

[30]  Jianhua Zhang,et al.  Cellular metabolic and autophagic pathways: traffic control by redox signaling. , 2013, Free radical biology & medicine.

[31]  K. Pantel,et al.  Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. , 2010, Journal of proteome research.

[32]  K. Wakasa,et al.  HER2 overexpression correlates with survival after curative resection of pancreatic cancer , 2009, Cancer science.

[33]  G. Kroemer,et al.  Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.